Beneficial Drugs For Liver Diseases.
P. Muriel, Y. Rivera-Espinoza
Published 2008 · Medicine
Download PDFAnalyze on Scholarcy
Liver diseases are a major problem of worldwide proportions. However, the number of drugs actually used successfully in humans is very small. In this review some of the most promising/studied drugs utilized for liver diseases were chosen and analysed critically from the basic to the clinical point of view. Antiviral agents are not discussed because excellent reviews have appeared on this topic. The compounds/preparations described herein are, alphabetically: colchicine, corticosteroids, curcumin, glycyrrhizin, interferons (for their antifibrotic properties), Liv 52, nitric oxide, resveratrol, silymarin, sulfoadenosylmethionine, and thalidomide. Colchicine and corticosteroids have been studied extensively in animals and humans; most clinical studies suggest that these compounds are not useful in the treatment of liver diseases. Glycyrrhizin is an herbal medicine with several components that has interesting hepatoprotective properties in patients with subacute liver failure but deserves more prospective controlled trials. Interferon has shown interesting antifibrotic properties in animals and humans; prospective studies on their antifibrotic/fibrolytic activity are required. Curcumin, resveratrol and thalidomide are very attractive newly discovered protective and curative compounds on experimental hepatic diseases. Their mechanism of action is associated with the ability to down-regulate NF-kappaB and to decrease pronecrotic and profibrotic cytokines. Unfortunately, clinical studies are lacking. Sulfoadenosylmethionine and silymarin are also promising drugs utilized mainly in cholestasis but the benefits can be expanded if more controlled trials are performed. The future is to carry out controlled prospective double-blind multicenter studies with the newly discovered drugs with proven beneficial effects on animals. Fundamental hepatobiology should also be encouraged.
This paper references
Colchicine prevents D-galactosamine-induced hepatitis.
M. Mourelle (1989)
Effects of S-adenosyl-L-methionine and interferon-alpha2b on liver damage induced by bile duct ligation in rats.
P. Muriel (1998)
Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
M. Li (2007)
Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects.
S. Malawista (1968)
Gamma-interferon inhibits collagen synthesis in vivo in the mouse.
R. Granstein (1987)
Hepatoprotective properties of Silybum marianum herbal preparation on ethanol-induced liver damage
M. Wang (1996)
Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress.
Karina Reyes-Gordillo (2007)
Herbal Medicines for Liver Diseases
R. Dhiman (2005)
The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach.
H. F. Huseini (2005)
Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats.
P. Muriel (1997)
Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator.
L. Rodríguez-Fragoso (1995)
Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis.
I. Tasci (2007)
Protective effect of resveratrol against oxidative stress in cholestasis.
C. Ara (2005)
Effect of colchicine on acetaminophen-induced liver damage.
P. Muriel (1993)
Molecular mechanism of the chemopreventive effect of resveratrol.
Z. Dong (2003)
Protective and therapeutic effect of silymarin on the development of latent liver damage.
K. Kropáčová (1998)
Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane Review
A. Rambaldi (2002)
Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats
E. Chávez (2008)
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
Wei-Shi Yeh (2007)
Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages.
T. Wadsworth (1999)
Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat.
Eduardo Fernández-Martínez (2004)
Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine.
U. Pendurthi (1999)
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
P. Mathurin (2002)
Regulation of nitric oxide synthesis in the liver.
P. Muriel (2000)
Thalidomide--a revival story.
Nishita Raje (1999)
Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach.
P. Muriel (1994)
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
H. Yoshiji (2006)
S‐Adenosylmethionine: a control switch that regulates liver function
J. A. Mato (2002)
Colchicine in the treatment of cirrhosis of the liver.
D. Kershenobich (1988)
Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells.
J. Liu (1993)
S-adenosylmethionine synthesis: molecular mechanisms and clinical implications.
J. Mato (1997)
Interaction of some colchicine analogs, vinblastine and podophyllotoxin with rat brain microtubule protein.
M. Zweig (1973)
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma
B. Chuah (2007)
Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats.
Lee-Won Chong (2006)
Characterization of membrane fraction lipid composition and function of cirrhotic rat liver. Role of S-adenosyl-L-methionine.
P. Muriel (1992)
Prevention by silymarin of membrane alterations in acute CCl4 liver damage.
P. Muriel (1990)
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
T. Walle (2004)
Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.
J. Barbour (2006)
Update on viral hepatitis: 2006
J. Tan (2007)
Signal transduction in hepatic stellate cells.
M. Pinzani (1998)
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
J. A. Mato (1999)
Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
S. Mukherjee (2006)
Treatment of patients with alcoholic liver disease.
F. Zhang (2005)
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*)
S. Singh (1995)
Effect of α‐Interferon and α‐Tocopherol in Reversing Hepatic Cirrhosis in Rats
T. Mathew (2007)
Interferon alfa down‐regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice
Y. Inagaki (2003)
Colchicine in the Experimental Chemotherapy of Cancer
R. Ludford (1945)
Studies in methionine and sulfur metabolism; the fate of intravenously administered methionine, in normal individuals and in patients with liver damage.
L. Kinsell (1948)
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
S. Pradhan (2006)
Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice.
N. Abe (1982)
Protective effects of resveratrol against acetaminophen-induced toxicity in mice.
G. Şener (2006)
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
L. Weber (2003)
Some Experimental Models of Liver Damage
P. Muriel (2008)
Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine.
P. Muriel (1998)
Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice.
K. Okada (2001)
Complementary and alternative medicine in chronic liver disease
L. Seeff (2001)
Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rat
P. Muriel (2003)
Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of glycyrrhizin.
C. Miyaji (2002)
Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes.
M. Goldring (1986)
Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
M. Miller (1999)
A review of plants used in the treatment of liver disease: part two.
S. Luper (1999)
Prevention of liver cirrhosis in rats by curcumin.
R. Bruck (2007)
Inhibitory Effects of Curcumin and Tetrahydrocurcuminoids on the Tumor Promoter‐induced Reactive Oxygen Species Generation in Leukocytes in vitro and in vivo
Y. Nakamura (1998)
S-adenosyl-L-methionine prevents and reverses erythrocyte membrane alterations in cirrhosis.
P. Muriel (1993)
Pharmacology of Curcuma longa.
H. P. Ammon (1991)
Metabolism of curcumin--studies with [3H]curcumin.
V. Ravindranath (1981)
Down regulation of tumour necrosis factor activity in experimental hepatitis by a herbal formulation, Liv. 52.
A. Roy (1994)
Biological effects of resveratrol.
L. Frémont (2000)
Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody.
Y. Shiki (1992)
Protective effect of silymarin on rat liver injury induced by ischemia
C. G. Wu (1993)
The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*)
B. Darnay (1995)
γ‐interferon treatment inhibits collagen deposition in murine schistosomiasis
Mark J. Czaja (1989)
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes.
G. Giannelli (2006)
Update on viral hepatitis.
A. Narbey (2005)
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity.
G. Muller (1996)
Does interferon improve portal hypertension?
D. Rincón (2006)
Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat.
H. Rivera (2008)
Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
M. Lucena (2002)
Effects of glycyrrhizin on immune-mediated cytotoxicity.
M. Yoshikawa (1997)
Effects of thalidomide and 3‐phthalimido‐3‐(3,4‐dimethoxyphenyl)‐propanamide on bile duct obstruction‐induced cirrhosis in the rat
E. Fernández-Martínez (2001)
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
K. Flora (1998)
Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
A. Muir (2006)
Hepatoprotective effects of Liv-52 on ethanol induced liver damage in rats.
R. Sandhir (1999)
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
R. M. Palmer (1987)
Studies on the hypothetical relationship of thalidomide-induced embryopathy and collagen biosynthesis.
L. Flohe (1981)
A role for the microtubular system in the release of very low density lipoproteins by perfused mouse livers.
Y. le Marchand (1973)
The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin.
P. Muriel (1990)
Effect of picroliv and silymarin on liver regeneration in rats
Srivastava Savita (1994)
Effect of silymarin and silybinin on oxygen radicals
Carlos Pascual (1993)
PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN
M. Mourelle (1989)
Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice.
S. Giri (1986)
Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.
C. Rao (1995)
Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
L. Pari (2004)
Multiple biological activities of curcumin: a short review.
R. Maheshwari (2006)
Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice.
M. G. Moreno (2006)
Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride.
P. Muriel (1998)
Current concepts in the pathogenesis of alcoholic liver injury
H. Tsukamoto (2001)
Role of S‐adenosyl‐L‐methionine in liver health and injury
J. Mato (2007)
Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats.
A. Kasdallah-Grissa (2006)
Prevention of hepatic fibrosis in nonobese diabetic mice: a critical role for interferon-gamma.
T. Mukai (2006)
Effect of alpha-interferon on erythrocyte and hepatocyte plasma membranes derived from cirrhotic rats.
P. Muriel (1994)
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
B. Aggarwal (2004)
Effect of colchicine and trimethylcolchicinic acid on CCl4-induced cirrhosis in the rat.
A. Cedillo (1996)
Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
T. Tanaka (1994)
Thalidomide as an emerging immunotherapeutic agent.
J. Marriott (1999)
Remission of liver fibrosis by interferon-α2b
M. G. Moreno (1995)
Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages.
Y. Abe (1999)
Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests.
B. Fauconneau (1997)
Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study.
H. Salmi (1982)
Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine.
R. Pascale (2002)
Silymarin protects against paracetamol-induced lipid peroxidation and liver damage.
P. Muriel (1992)
Effects of interferon plus ribavirin treatment on NF-κB, TGF-β1, and metalloproteinase activity in chronic hepatitis C
M. Guido (2006)
Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated wth decreaded levels of the procollagen mRNAs(FEBS 2156)
M. L. Stephenson (1985)
Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
P. Muriel (2005)
Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C
M. Šimin (2007)
Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells
N. Kawada (1998)
Role of nitric oxide in the antifibrotic and anticholestatic actions of interferon‐α2b
P. Muriel (1999)
Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion.
M. Huang (1995)
Interferon-alpha preserves erythrocyte and hepatocyte ATPase activities from liver damage induced by prolonged bile duct ligation in the rat.
P. Muriel (1995)
Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood.
L. Spahr (2001)
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
A. Moreira (1993)
Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats.
L. Pari (2005)
The effects of silybin on experimental phalloidine poisoning.
J. Choppin (1978)
10 Curcumin — Biological and Medicinal Properties
B. Aggarwal (2006)
Cytokines in Liver Diseases
P. Muriel (2008)
Comparative study of colchicine and trimethylcolchicinic acid on prolonged bile duct obstruction in the rat.
V. Castro (1996)
Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
L. Jin (2007)
Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrol
S. H. Tsai (1999)
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
C. Ireson (2001)
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice1
C. Tabata (2007)
This paper is referenced by
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Forouzan Faghihzadeh (2014)
Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity
Neha Singh (2015)
Dietary Antioxidants in Experimental Models of Liver Diseases
Sila Appak-Baskoy (2019)
Investigation by Histopathological and TUNEL Method of the Protective Effect of Resveratrol on Carbon Tetrachloride Induced Liver Toxicity in Rats
S. Yıldırım (2017)
Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats
K. Amin (2009)
Hepatoprotective properties of extensively studied medicinal plant active constituents: Possible common mechanisms
H. Farghali (2015)
Resveratrol and liver: A systematic review
Forouzan Faghihzadeh (2015)
HEPATOPROTECTIVE EFFICACY OF METHANOLIC EXTRACT OF INDIGOFERA SUFFRUTICOSA (MILL) ON PARACETAMOL-INDUCED LIVER DAMAGE IN MICE.
Izabela Rangel Lima (2019)
Hepatoprotective Effects of Berberis vulgaris L. Extract/β Cyclodextrin on Carbon Tetrachloride–Induced Acute Toxicity in Mice
A. Hermenean (2012)
Clinical Effects of Safflower Pill of Dedu Seven Medicinal Herbs Plus Adefovir Dipivoxil on Liver Fibrosis Resulting from Chronic Viral Hepatitis B
Yi Na (2017)
Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats.
Zhi-xing Zhou (2011)
Characterization of polysaccharides with antioxidant and hepatoprotective activities from the wild edible mushroom Russula vinosa Lindblad.
Q. Liu (2014)
Evaluation of Phytochemical, Antioxidant and Hepatoprotective Activity of Tuber of Geodorum laxiflorum Griff
Ram Chandra Besra (2011)
Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats
Kyoung Ook Cheong (2016)
Protective effect of Tritone (Livosone) on oxidative DNA damage and its hepatoprotective potential against various hepatotoxic agent in wistar rats.
Sheetal Kashinath Medhekar (2017)
Hepatoprotective effect of Woodfordia fruticosa Kurz flowers on diclofenac sodium induced liver toxicity in rats.
Yogesh Baravalia (2011)
Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress
M. H. Hassan (2016)
In vitro and in vivo antioxidant activity of a fructan from the roots of Arctium lappa L.
Wei Liu (2014)
Glycyrrhetinic acid alleviates radiation-induced lung injury in mice
Jinmei Chen (2017)
A novel drug induced hybrid electrospun PCL - cell derived ECM scaffold for liver tissue engineering
Rhiannon Grant (2017)
GC/MS profile, DNA protectant and hepatoprotective effects of Praecitrullus fistulosus fruit methanol extract.
Chakkere Shivmadhu Madhu (2019)
NF-kappaB in liver diseases: a target for drug therapy.
P. Muriel (2009)
Protective effects of HV-P411 complex against D-galactosamine-induced hepatotoxicity in rats.
Jung-Woo Kang (2012)
Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis.
Naglaa M El-Lakkany (2017)
Development of a cellular predictive model of inflammation associated idiosyncratic drug-induced hepatotoxicity and investigation of its underlying cellular and molecular mechanisms
Léa Saab (2013)
Phytochemical constituents, antioxidant and chemopreventive effects of selected plants against carbon tetrachloride (CCI₄)- inducedhepatic damage in rats
M. D. Shah (2016)
Hepatoprotective Potential of Flavonoid Rich Fraction of Enhydra Fluctuans Against CCl 4-Induced Oxidative Damage in Rats
S. Sannigrahi (2009)
Glycyrrhizin renders cells resistant to apoptosis induced by human and feline immunodeficiency virus
Hitoshi Sato (2011)
Hepatoprotective Action of Echinophora platyloba DC Leaves Against Acute Toxicity of Acetaminophen in Rats
Esfandiar Heidarian (2014)
Hepatoprotective effects of silymarin coated gold nanoparticles in experimental cholestasis.
S. Clichici (2020)
Precursor-Directed Biosynthesis of Curcumin Analogs in Escherichia coli
Y. Katsuyama (2010)
Protective effects of Cambodian medicinal plants on tert‑butyl hydroperoxide‑induced hepatotoxicity via Nrf2‑mediated heme oxygenase‑1.
Dong-Sung Lee (2017)See more